PRQR ProQR Therapeutics N.V.
Nasdaq · SEC CIK 1612940 · EDGAR
- Bought, last 12 months
- $1.34M 5 purchases by 2 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 7 since 2026-06-03, latest 2026-08-03 16:01
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| de Boer Daniel Anton | CEO, Dir | $853.5K | — |
| Filius Bart | Dir | $488.9K | — |
Transactions 5
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-03 16:01 | 2026-07-31 | PRQR | de Boer Daniel Anton | CEO, Dir | P - Purchase | $1.77 | +200.0K | 500.0K | +67% | +$354.0K | |
| 2026-07-21 08:00 | 2026-07-17 | PRQR | Filius Bart | Dir | P - Purchase | $1.72 | +150.0K | 300.0K | +100% | +$257.9K | |
| 2026-07-13 08:00 | 2026-07-09 | PRQR | de Boer Daniel Anton | CEO, Dir | P - Purchase | $1.74 | +150.0K | 300.0K | +100% | +$261.0K | |
| 2026-07-08 14:55 | 2026-07-07 | PRQR | de Boer Daniel Anton | CEO, Dir | P - Purchase | $1.59 | +150.0K | 150.0K | New | +$238.5K | |
| 2026-06-30 16:01 | 2026-06-26 | PRQR | Filius Bart | Dir | P - Purchase | $1.54 | +150.0K | 150.0K | New | +$231.0K |
Purchase Sale Sale after option exercise All abbreviations